ADVANCED MALIGNANT SOLID TUMORS
Clinical trials for ADVANCED MALIGNANT SOLID TUMORS explained in plain language.
Never miss a new study
Get alerted when new ADVANCED MALIGNANT SOLID TUMORS trials appear
Sign up with your email to follow new studies for ADVANCED MALIGNANT SOLID TUMORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New weapon against advanced cancer begins human testing
Disease control Recruiting nowThis is the first-ever study in humans of an experimental antibody called GEN1057 for treating advanced solid tumors. The trial aims to find a safe dose and see early signs of whether the treatment can shrink tumors. It will enroll about 45 adults with metastatic or advanced canc…
Matched conditions: ADVANCED MALIGNANT SOLID TUMORS
Phase: PHASE1 • Sponsor: Genmab • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
New Two-Drug attack on Tough-to-Treat cancers
Disease control Recruiting nowThis study is testing a new oral drug, FC084CSA, given alongside an existing immunotherapy called tislelizumab. The goal is to find a safe and effective dose for treating patients with advanced solid tumors that have worsened despite standard therapies. The trial will first find …
Matched conditions: ADVANCED MALIGNANT SOLID TUMORS
Phase: PHASE1, PHASE2 • Sponsor: FindCure Biosciences (ZhongShan) Co., Ltd. • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
Groundbreaking oral cancer pill enters human testing
Disease control Recruiting nowThis is the first human study of an experimental oral medication called CSCJC3456 for people with advanced solid tumors that have stopped responding to standard treatments. The trial aims to find safe doses and see how the drug behaves in the body, while also checking if it can s…
Matched conditions: ADVANCED MALIGNANT SOLID TUMORS
Phase: PHASE1 • Sponsor: Changshan ConjuChem BioPharmaceutical Research and Development (Hebei) Co., Ltd. • Aim: Disease control
Last updated Mar 19, 2026 15:05 UTC
-
New cancer drug enters first human testing for advanced tumors
Disease control Recruiting nowThis is the first human study of an experimental cancer drug called JSKN022. It aims to find a safe dose and check for early signs that the drug might help control advanced solid tumors in patients who have run out of standard treatment options. The study will enroll about 225 ad…
Matched conditions: ADVANCED MALIGNANT SOLID TUMORS
Phase: PHASE1 • Sponsor: Jiangsu Alphamab Biopharmaceuticals Co., Ltd • Aim: Disease control
Last updated Feb 23, 2026 14:51 UTC